Clinical Trials
23 trialsNCT07526493 2026-05-12
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Tongji Hospital
Phase 1 Recruiting
NCT07085676 2026-05-06
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Hadassah Medical Organization
Phase 1 Recruiting
NCT00716066 2026-02-27
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Fred Hutchinson Cancer Center
Phase 2 Active not recruiting
NCT07392528 2026-02-11
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07333196 2026-01-21
Tongji NADs Cohort
Tongji Hospital
Not yet recruiting
NCT01623076 2026-01-06
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
University of Texas Southwestern Medical Center
Active not recruiting
NCT06939166 2025-12-15
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Phase EARLY_PHASE1 Recruiting
NCT00445367 2025-10-02
Biobank For MS And Other Demyelinating Diseases
Accelerated Cure Project for Multiple Sclerosis
Active not recruiting
NCT06249438 2025-07-25
CAR-AID
RenJi Hospital
Phase 1 Recruiting
NCT07022197 2025-06-15
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Tianjin Medical University General Hospital
Phase 1/2 Recruiting
NCT06941584 2025-04-24
NAD-AIRE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT06485232 2025-01-01
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1 Not yet recruiting
NCT05017142 2024-12-16
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
University of Bern
Recruiting
NCT06502015 2024-11-20
Biomarkers in Autoimmune Disease of Nervous System
Tongji Hospital
Recruiting
NCT04561557 2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1 Recruiting
NCT06443333 2024-06-05
NIDBase
Xuanwu Hospital, Beijing
Unknown
NCT03942952 2023-09-05
SONICS
University of Texas Southwestern Medical Center
Completed
NCT05245344 2022-02-17
Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study
Neuromed IRCCS
Unknown
NCT00304291 2020-12-28
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
State University of New York at Buffalo
Phase 4 Completed
NCT02276963 2019-06-06
Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Johns Hopkins University
Phase 1 Completed
NCT02166346 2018-04-17
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
Johns Hopkins University
Phase 2 Completed
NCT02398994 2016-07-20
STRIVE
Guy's and St Thomas' NHS Foundation Trust
Phase 3 Terminated
NCT00501748 2011-09-27
Safety and Tolerability of Rituximab in Neuromyelitis Optica
University of California, San Francisco
Phase 1 Completed